POEMS syndrome (or Crow-Fukase syndrome);Le syndrome POEMS (ou syndrome de Crow-Fukase)

Revue Neurologique

Volumn 160, Issue 3, 2004, Pages 285-295

  Lagueny, A ^a,b   Bouillot, S ^b,c   Vital, C ^b,c   Ferrer, X ^a   Larrieu, J M ^d   Vital, A ^b,c  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b Neurobiol des Affect de la Myeline   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d CENTRE HOSPITALIER DE PAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA CHAIN;

ANASARCA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOMA; CLINICAL EXAMINATION; CLINICAL FEATURE; CROW FUKASE SYNDROME; CUTANEOUS GLOMERULOID ANGIOMA; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; ENDOCRINE DISEASE; HUMAN; JAPAN; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE BIOPSY; NOMENCLATURE; PAPILLEDEMA; PARAPROTEINEMIA; PLASMACYTOMA; POLYNEUROPATHY; PUVA; REVIEW; SCLEROSING PLASMACYTOMA; SKIN MANIFESTATION; THROMBOCYTOSIS; ULTRASTRUCTURE;

EID: 1642366222     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(04)70903-0     Document Type: Article

References (113)

1. ADAMS D, SAID G. (1998). Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry, 64: 809-812.
2. ADAMS D, SCHAEFFER S, CHAPON F. (2000). Neuropathie périphé rique sensitivo-motrice, hyperprotéinorachie et immunoglobuline IgG monoclonale chez un homme de 38 ans. Rev Neurol (Paris), 156: 1166-1170.
3. ADELMAN HM, CACCIATORE ML, PASCUAL JF, MIKE JM, ALBERTS WM, WALLACH PM. (1994). Castleman disease in association with POEMS. Am J Med Sci, 307: 112-114.
4. AMIEL JL, MACHOVER D, DROZ JP. (1975). Dyscrasie plasmocytaire avec artériopathie, polyneuropathie, syndrome endocrinien. Une maladie japonaise chez un italien. Ann Med Interne, 126: 745-749.
5. AUBERT L, GATFOSSE M, JEUNHOMME G, LEGER JM, BOLGERT F, SCHERPEREL B. (1983). Myélome condensant avec polyradiculonévrite, hyperpigmentation et hypertrichose. Press Med, 12: 961-962.
6. BARDWICK PA, ZVAIFLER NJ, GILL GN, NEWMAN D, GREENWAY GD, RESNICK DL. (1980). Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine, 59: 311-322.
7. BARRIER JH, LE NOAN H, MUSSINI JM, BRISSEAU JM. (1989). Stabilisation of a severe case of POEMS syndrome after tamoxifen administration. J Neurol Neurosurg Psychiatry, 52: 286-290 (Letter).
8. BÉLEC L, SI MOHAMED A, AUTHIER FJ et al. (1999). Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood, 93: 3643-3653.
9. BENITO-LÉON J, LOPEZ-RIOS F, RODRIGUEZ-MARTIN FJ, MADERO S, RUIZ J. (1998). Rapidly deteriorating polyneuropathy associated with osteosclerotic myeloma responsive to intravenous immunoglobulin and radiotherapy. J Neurol Sci, 158: 113-117.
10. BERGOUIGNAN FX, MASSONNAT R, VITAL C, BARAT M, HENRY P, LENG B, EFFROY C. (1987). Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol, 27: 173-181.
11. BERKOVIC SF, SCARLETT JD, SYMINGTON GR, DENNETT X, WOODRUFF RK. (1986). Proximal motor neuropathy, dermato-endocrine syndrome, and IgGκ paraproteinemia. Arch Neurol, 43: 845-848.
12. BITTER MA, KOMAIKO W, FRANKLIN WA. (1985). Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki's) syndrome. Cancer, 56: 188-194.
13. BOURDETTE DN, ROSENBERG NL. (1984). Infiltrative orbitopathy, optic disk edema, and POEMS. Neurology, 34: 532-533.
14. BROUSOLLE E, VIGHETTO A, BANCEL B, CONFAVREUX C, PIALAT J, AIMARD G. (1991). POEMS syndrome with complete recovery after treatment of a solitary plasmocytoma. Clin Neurol Neurosurg, 93: 165-170.
15. CABEZAS-AGRICOLA JM, LADO-ABEAL JJ, OTERO-ANTON E, SANCHEZ-LEIRA J, CABEZAS-CERRATO J. (1996). Hypoparathyroidism in POEMS syndrome. Lancet, 347: 701-702.
16. CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. (1992). Case 39 - 1992. A 49-year-old woman with perpheral neuropathy, hepatosplenomegaly and intermittent abdominal pain. N Engl J Med, 32:1014-1021.
17. CHAN JKC, FLETCHER CDM, HICKLIN GA, ROSAI J. (1990). Glomeruloid hemangioma: a distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol, 14: 1036-1046.
18. CHARIF M, BLARD JM, PAGÈS M. (2000). Syndrome POEMS à révélation ophtalmologique. Rev Neurol (Paris), 156: 1151-1153.
19. CRISCI C, BARBIERI F, PARENTE D, PAPPONE N, CARUSO G. (1992). POEMS syndrome: follow-up study of a case. Clin Neurol Neurosurg, 94: 65-68.
20. CROW RS. (1956). Peripheral neuritis in myelomatosis. Br Med J, 2: 802-804.
21. DELALANDE S, STOJKOVlC T, ROSE C, MILLAIRE A, HURTEVENT JF, VERMESCH P. (2002). Paralysie phrénique bilatérale, dysautonomie et cardiomyopathie restrictive dans un cas de syndrome POEMS. Rev Neurol (Paris), 158: 737-740.
22. DIDUSZYN JM, QUILLEN DA, CANTORE WA, GARDNER TW. (2002). Optic disk drusen, peripapillary choroidal neovascularization, and POEMS syndrome. Am J Ophthalmol, 133: 275-276.
23. DISPENZIERI A, KYLE RA, LACY MQ et al. (2003). POEMS syndrome: definitions and long-term outcome. Blood, 101: 2496-2506
24. DONAGHY M, HALL P, GAWLER J et al. (1989). Peripheral neuropathy associated with Castleman's disease. J Neurol Sci, 89: 253-267.
25. DRIEDGER H, PRUZANSKI W. (1980). Plasma cell neoplasia with peripheral polyneuropathy: a study of five cases and a review of the literature. Medicine, 59: 301-310.
26. DUPIN N, DISS TL, KELLAM P et al. (2000). HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 95:1406-1412.
27. GABREËLS-FESTEN AAWM, HOOGENDIJK JE, MEIJERINK PHS et al. (1996). Two divergent types of nerve pathology in patients with different Po mutations in Charcot-Marie-Tooth disease. Neurology, 47: 761-765.
28. GANDHI D, VASHISHT S, MAHAJAN A, KAPPOR A, BERRY M. (2000). Proptosis with orbital soft tissue and bone changes and unilateral papilloedema: unusual presentation of POEMS syndrome. J Clin Imag, 24: 193-196.
29. GATINEL D, LARROCHE C, FANJKUCHEN F, CHAINE G, GUILLEVIN L. (1998). Œdème papillaire et syndrome POEMS. J Fr Ophtalmol, 21: 133-141.
30. GHERARDI R, ZUBER M, VIARD JP. (1988 a). Les neuropathies dysglobulinémiques. Rev Neurol (Paris), 144: 391-408.
31. GHERARDI R, BAUDRIMONT M, KUJAS M, MALAPERT D, LANGE F, GRAY F, POIRIER J. (1988b). Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat, 413: 357-365.
32. GHERARDI R, MALAPERT D, DEGOS JD. (1991). Castleman disease-POEMS syndrome overlap. Ann Intern Med, 114: 520 (lettre).
33. GHERARDI R, BELEC L, FROMONT G, DIVINE M, MALAPERT D, GAULARD P, DEGOS JD. (1994a). Elevated levels of interleukine-1β (IL-1β) and IL-6 in serum, and increased production of IL-1β mRNA in lymph nodes of patients with POEMS syndrome. Blood, 83: 2587-2593.
34. GHERARDI RK, CHOUAÏB S, MALAPERT D, BELEC L, INTRATOR L, DEGOS JD. (1994b). Early weight loss and high serum tumor necrosis factor-α levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Ann Neurol, 35: 501-505.
35. GHERARDI RK, BÉLEC L, SOUBRIER M et al. (1996a). Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood, 87: 1458-1465.
36. GHERARDI RK, AUTHIER FJ, BELEC L. (1996b). Les cytokines pro-inflammatoires: une clé pathogénique du syndrome POEMS. Rev Neurol (Paris), 152: 409-412.
37. GIMENEZ-ROQUEPLO AP, CASANOVA S, BRUCKERT E, BOLGERT F, TURPIN G. (1994). Les endocrinopathies dans le POEMS syndrome: à propos de 4 observations. Presse Med, 23: 1243-1246.
38. GOEBELS N, WALTHER EU, SCHALLER M, PONGRATZ D, MUELLER-FELBER W. (2000). Inflammatory myopathy in POEMS syndrome. Neurology, 55: 1413-1414.
39. HASHIGUCHI T, ARIMURA K, MATSUMURO K et al. (2000). Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve, 23: 1051-1056.
40. HERRADA J, CABANILLAS F, RICE L, MANNING J, PUGH W. (1998). The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med, 128: 657-662.
41. HYMAN BT, WESTRICK MA. (1986). Multiple myeloma with polyneuropathy and coagulopathy. A case report of the polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin change (POEMS) syndrome. Arch Intern Med, 146: 993-994.
42. ICHIKAWA Y, NAKATA T, OHHATA J et al. (2001). Crow-Fukase syndrome with ischemic cardiomyopathy. Intern Med, 40: 726-730.
43. IWASHITA H, OHNISHI A, ASADA M, KANAZAWA Y, KUROIWA Y. (1977). Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology, 27: 675-681.
44. JACCARD A, ROYER B, BORDESSOULE D, BROUET JC, FERMAND JP. (2002). High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood, 99: 3057-3059.
45. KIM DE, KIM HJ, KIM YA, LEE KW. (2000). Kaposi's sarcoma herpesvirus-associated Castleman's disease with POEMS syndrome. Muscle Nerve, 23: 436-439.
46. King RHM. (1999). Atlas of peripheral nerve pathology. Arnold. London.
47. KOGA H, TOKUNAGA Y, HISAMOTO T et al. (2002). Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med, 13: 70-74.
48. KOIKE H, SOBUE G. (2000). Crow-Fukase syndrome. Neuropathol, 20: S69-S72.
49. KUWABARA S, HATTORI T, SHIMOE Y, KAMITSUKASA I. (1997). Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry, 63: 385-387.
50. LAGUENY A, LATOUR P, VITAL A et al. (1999). Peripheral myelin modification in CMT1B correlates with MPZ gene mutations. Neuromusc Dis, 9: 361-367.
51. LAMBOTTE O, DÜRRBACH A, AMMOR M, PARADIS V, DJEFFAL R, MACHOVER D, CHARPENTIER B. (2001). Association of a POEMS syndrome and light chain deposit disease: first case report. Clin Nephrol, 55: 482-486.
52. LAPRESLE J, LACROIX-CIAUDO C, REYNÈS M, MADOULÉ P. (1986). Syndrome de Crow-Fukase (« POEMS syndrome ») et mastocytose osseuse secondaires à une hyperplasie lymphoïde angiofolliculaire de Castleman. Rev Neurol (Paris), 142: 731-737.
53. LESPRIT P, AUTHIER FJ, GHERARDI R, BELEC L, MELLIÈRE S, SCHAEFFER A, GODEAU B. (1996). Acute arterial obliteration: a new feature of POEMS syndrome mediated by proinflammatory cytokines? Medicine, 75: 226-232.
54. MAHIEUX F, BAUDRIMONT M, FENELON G, HEINZLEF O, BAKOUCHE P, SABOURIN P, GUILLARD A. (1991). POEMS guéri par le traitement radical d'un plasmocytome. Rev Neurol (Paris), 147: 231-233.
55. MALAPERT D, GHERARDI R. (1992). Syndrome POEMS et maladie de Castleman. In: Neuropathies périphériques: polyneuropathies et mononeuropathies multiples. P Bouche, JM Vallat (Eds): 348-356. Doin, Paris.
56. MANDLER RN, KERRIGAN DP, SMART J, KUIS W, VILLIGER P, LOTZ M. (1992). Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer, 69: 2697-2703.
57. MANDLER RN, KING MK. (1996). Myeloneuropathy in POEMS syndrome. Muscle Nerve, 19:1614-1616.
58. MANO T, MORI K, SAWAI Y et al. (1999). Accelerated conversion of dehydroepiandro-sterone sulfate to estrogen in a patient with Crow-Fukase syndrome and diabetes mellitus. Endocr Res, 25: 371-380.
59. MAUVAIS-JARVIS F, BERTHERAT J, RAVAUD H, THOMOPOULOS P, LUTON JP. (1998). Syndrome de POEMS avec insuffisance surrėnalienne primaire. Presse Med, 27:15-17.
60. MICHIZONO K, UMEHARA F, HASHIGUCHI T et al. (2001). Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology, 56: 807-810.
61. MIDRONI G, BILBAO JM. (1995). Biopsy diagnosis of peripheral neuropathy. Butterworth-Heinemann. Boston.
62. MINAMITAMI S, OHFUJI S, NISHIGUCHI S et al. (2002). An autopsy case of POEMS syndrome with a high level of IL-6 and VEGF in the serum and ascitic fluid. Intern Med, 41: 233-236.
63. MIRALLES GD, O'FALLON JR, TALLEY NJ. (1992). Plasma-cell dyscrasia with polyneuropathy: the spectrum of POEMS syndrome. N Engl J Med, 327: 1919-1923.
64. MIZUIRI S, MITSUO K, SAKAI K et al. (1991). Renal involvement in POEMS syndrome. Nephron, 59: 153-156.
65. MURPHY PT, AHMED N, HASSAN HT. (2002). Chronic myeloid leukemia and acromegaly in POEMS syndrome. Leuk Res, 26: 1135-1137.
66. NAKAMOTO Y, IMAI H, YASUDA T, WAKUI H, MIURA AB. (1999). A spectrum of clinicopatological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant, 14: 2370-2378.
67. NAKANISHI T, SOBUE I, TOYOKURA Y et al. (1984). The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology, 34: 712-720.
68. NISHITANI H, KUNO S, HAEBARA H et al. (1984). Pathology and classification of Crow-Fukase syndrome. In: Sobue I (ed), Peripheral neuropathy. pp. 378-386. Excerpta Medica. Amsterdam.
69. OHI T, KYLE RA, DYCK PJ. (1985). Axonal attenuation and secondary segmental demyelination in myeloma neuropathies. Ann Neurol, 17: 255-261.
70. OHNISHI A, HIRANO A. (1981). Uncompacted myelin lamellae in dysglobulinemic neuropathy. J Neurol Sci, 51: 131-140.
71. OHNISHI A. (1984). Geographical patterns of neuropathy: Japan. In: Asbury AK, Gilliat RW (eds). Peripheral nerve disorders. A practical approach. pp. 303-319. Butterworths. London.
72. OREFICE G, BRESCIA MORRA V, DE MICHELE G, Fusco C, BORGIA G, CERINI R, BARBIERI F. (1994). POEMS syndrome: clinical, pathological and immunological study of a case. Neurol Res, 16: 477-480.
73. PAPO T, SOUBRIER M, MARCELIN AG et al. (1999). Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome. Br J Haematol, 104: 932-933.
74. PAREYSON D, MARAZZI R, CONFALONIERI P, MANCARDI GL, SCHENONE A, SGHIRLANZONI A. (1994). The POEMS syndrome: report of six cases. Ital J Neurol Sci, 15: 353-358.
75. PAVORD SR, MURPHY PT, MITCHELL VE. (1996). POEMS syndrome and Waldenström's macroglobulinaemia. J Clin Pathol, 49: 181-182.
76. PETRELLA T, DALAC S, BIELFELO P, BESANCENOT JF, LAMBERT D, MICHIELS R. (1994). Tumeur cutanée chez une patiente atteinte d'un POEMS syndrome. Ann Pathol, 14: 47-48.
77. REULECKE M, DUMAS M, MEIER C. (1988). Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology, 38: 614-616.
78. ROMAS E, STOREY E, AYERS M, BYRNE E. (1992). Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG κ paraproteinemia. Pathology, 24: 217-220.
79. ROSE C, ZANDECKI M, COPIN MC et al. (1997). POEMS syndrome: report on six patients with unusual clinical signs, elevated level of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia, 11: 1318-1323.
80. ROTTA FT, BRADLEY WG. (1997). Marked improvement of severe polyneuropathy associated with multifocal osteosclerotic myeloma following surgery, radiation, and chemotherapy. Muscle Nerve, 20: 1035-1037.
81. ROVIRA M, CARRERAS E, BLADÉ J, GRAUS F, VALLS J, FERNADEZ-AVILÉS F, MONTSERRAT E. (2001). Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol, 115: 373-375.
82. SAIDA K, KAWAKAMI H, OHTA M, IWAMURA K. (1997). Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve, 20: 486-492.
83. SCHALLER M, ROMITI R, WOLLENBERG A, PRINZ B, WOERLE B. (2001). Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol, 45: 969-970.
84. SCHEERS C, KOLIVRAS A, CORBISIER A et al. (2002). POEMS syndrome revealed by multiple glomeruloid angiomas. Dermatology, 204: 311-314.
85. SEMBLE EL, CHALLA VR, HOLT DA, PISKO EJ. (1986). Light and electron microscopic findings in POEMS, or Japanese multisystem syndrome. Arthritis Rheum, 29: 286-291.
86. SHIBATA M, YAMADA T, TANAHASHI N, KOTO A, KURAMOCHI S, FUKUSHIMA S, FUKUUCHI Y. (2000). POEMS syndrome with necrotizing vasculitis: a novel feature of vascular abnormalities. Neurology, 54: 772-773.
87. SIMMONS Z, WALD J, ALBERS JW, FELDMAN EL. (1994). The natural history of a "benign" rib lesion in a patient with a demyelinating polyneuropathy and an unusual variant of POEMS syndrome. Muscle Nerve, 17: 1055-1059.
88. SOBUE G, DOYU M, WATANABE M, HAYASHI F, MITSUMA T. (1992). Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol, 84: 171-177.
89. SOLOMONS REB, GIBBS DD. (1982). Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome. J Roy Soc Med, 75: 553-555.
90. SOUBRIER MJ, DUBOST JJ, SAUVEZIE BJM, AND THE FRENCH STUDY GROUP ON POEMS SYNDROME. (1994). POEMS syndrome: a study of 25 cases and a review of the literature. Am J Med, 97: 543-553.
91. SOUBRIER M, DUBOST JJ, SERRE AF et al. (1997). Growth factors in POEMS syndrome: evidence for a marked increase of circulating vascular endothelial growth factor. Arthritis Rheum, 40: 786-787.
92. SOUBRIER M, RUIVARD M, DUBOST JJ, SAUVEZIE B, PHILIPPE P. (2002). Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant, 30: 61-62.
93. STERNBERG AJ, DAVIES P, MACMILLAN C, ABDUL-CADER A, SWART S. (2002). Strontium-89: a novel treatment for a case of osteosclerotic myeloma associated with life-threatening neuropathy. B J Haemat, 118: 821-824.
94. SUNG JY, KUWABARA S, OGAWARA K, KANAI K, HATTORI T. (2002). Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve, 26: 189-193.
95. TEIXEIRA F, ARANDA F, CABANAS A, ESTANOL B. (1990). POEMS syndrome: ultrastructural observations on the sural nerve. Ultra-struct Pathol, 14: 31-40.
96. TOYOKUNI S, EBINA Y, OKADA S et al. (1992). Report of a patient with POEMS/Takatsuki/Crow-Fukase syndrome associated with focal spinal pachymeningeal amyloidosis. Cancer, 70: 882-886.
97. TRENTHAM DE, MASI AT, MARKER HW. (1976). Polyneuropathy and anasarca: evidence for a new connective-tissue syndrome and vasculopathic contribution. Ann Int Med, 84: 271-274.
98. TRILLET M, FISCHER C, CHARHON S, BADY B, KOPP N, SCHOTT B. (1980). Polyradiculonévrite chronique avec signes cutanés et endocriniens révélatrice d'une dyscrasie plasmocytaire à IgA. Rev Neurol (Paris), 136: 247-258.
99. TSAI CY, LAI CH, CHAN HL, KUO TT. (2001). Glomeruloid hemangioma - a specific cutaneous marker of POEMS syndrome. Int J Dermatol, 40: 401-414.
100. TUITE PJ, BRIL V. (1997). POEMS syndrome in a 24-year-old man associated with vitamin B12 deficiency and a solitary lytic bone lesion. Muscle Nerve, 20: 1454-1456.
101. UMEHARA F, IZUMO S, ZYOUNOSONO M, OSAME M. (1990). An autopsied case of the Crow-Fukase syndrome: a neuropathological study with emphasis on spinal roots. Acta Neuropathol, 80: 563-567.
102. VALLAT JM, DE MASCAREL A, BORDESSOULE D, JAUBERTEAU MO, TABARAUD F, GELOT A, VALLAT AV. (1995). Non-Hodgkin malignant lymphomas and peripheral neuropathies: 13 cases. Brain, 118: 1233-1245.
103. VIARD JP, LESAVRE P, BOITARD C, NOEL LH, ROTH A, SAID G, BACH JF. (1988). POEMS syndrome presenting as systemic sclerosis: clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med, 84: 524-528.
104. VITAL A. (2001). Paraproteinemic neuropathies. Brain Pathol, 11: 399-407.
105. VITAL C, BRECHENMACHER C, REIFFERS J et al. (1983). Uncompacted myelin lamellae in two cases of peripheral neuropathy. Acta Neuropathol, 60: 252-256.
106. nd ed. Elsevier. New York.
107. VITAL C, VITAL A, SOUBRIER M, CLAVELOU P, KOPP N, SCHAEVERBEKE T, DEHAIS J. (1993). Pathology of the peripheral nerve in 8 cases of POEMS syndrome. In: SERRATRICE G (ed), Nervous system, muscles and systemic diseases. pp. 190-197. Expansion Scientifique Française. Paris.
108. VITAL C, GHERARDI R, VITAL A et al. (1994). Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome: ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol, 87: 302-307.
109. VITAL C, VITAL A, BOUILLOT S et al. (2003a). Uncompacted myelin lamellae in peripheral nerve biopsy. Ultrastructural Pathol, 27: 1-5.
110. VITAL C, BOUILLOT S, VITAL A. (2003b). Significance of uncompacted myelin lamellae in POEMS syndrome. Muscle Nerve, 27: 253-254.
111. WALDENSTRÖM JG. (1992). POEMS: a multifactorial syndrome. Haematologica, 77: 197-203.
112. WATANABE O, MARUYAMA I, ARIMURA K et al. (1998). Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve, 21: 1390-1397.
113. ZEA-MENDOZA AC, ALONSO-RUIZ A, GARCIA-VADILLO A, MORENO-CAPARROS A, BELTRAN-GUTIERREZ J. (1984). POEMS syndrome with neuroarthropathy and nodular regenerative hyperplasia of the liver. Arthritis Rheum, 27: 1053-1057.